Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0470
-0.0030 (-6.00%)
Oct 8, 2026, 2:23 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 32.91 million as of October 7, 2026. That makes Microba Life Sciences the world's 35,714th most valuable company and 914th in Australia. Its market cap has decreased by 36.41% in one year.
Market Cap
32.91M
Enterprise Value
29.07M
Revenue
14.76M
Global Rank
Country Rank
#914 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 32.91M, a decrease of -65.72%. That is a compound annual growth rate of -21.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 32.91M | -28.88% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 521.83M |
| Healius | 297.72M |
| Monash IVF Group | 290.28M |
| Cryosite | 56.13M |
| BCAL Diagnostics | 34.66M |
| Rhythm Biosciences | 26.89M |
| INOVIQ | 22.52M |
| Genetic Signatures | 17.94M |